Fetal DNA used to detect paternity from mother's blood; Tumor cells in blood signpost cancer metastasis;

> Fetal DNA can be used to detect paternity from the mother's blood at only 8 weeks of pregnancy. Article

> Ariosa Diagnostics has launched its Harmony Prenatal Test in the U.S. and Canada through Laboratory Corporation of America and Integrated Genetics; this is a non-invasive test for common fetal trisomies that detects cell-free DNA in maternal blood. Press release

> Islet Sciences has licensed technology from Yale University to develop and commercialize a biomarker of pancreatic beta-cell death. Press release

> Combining imaging and biomarkers could improve lung cancer diagnosis. Article

> Circulating tumor cells in non-metastatic breast cancer could be a surrogate marker for therapeutic selection and monitoring of the disease. Abstract

> QLIDA Diagnostics is developing a mobile cardiac biomarker testing device for use in emergency rooms to diagnose a heart attack or predict one happening in the near future. Article

> The Death Receptor 6 (DR6) protein has potential as a diagnostic and predictive biomarker for a number of epithelial tumors and sarcomas. Abstract

> A variant of the glucokinase regulator (GCKR) gene appears to have a link with the risk of colorectal cancer, according to a research team led by the University of Hawaii Cancer Center. Abstract

> The combination of three biomarkers--NGAL, resistin and procalcitonin--improved the diagnosis of serious bacterial infection in children in Malawi. Abstract

> Genomic Health and OncoMed Pharmaceuticals have signed an agreement to identify biomarkers to support the clinical development of OncoMed's novel antibody cancer therapeutics. Press release

> Biomarker company Nuclea Biotechnologies has raised $555,000. Article

> IL-8 shows potential as a biomarker in bladder cancer. Abstract

> OPKO Health has granted International Health Technology the rights to use its kallikrein biomarkers for the detection of prostate cancer in labs in the U.K., Ireland, Sweden and Denmark. Press release

And Finally… The Journal of Alzheimer's Disease has given Dr. Lönneborg and the team at DiaGenic the award for best scientific journal article in 2011, for a paper about an Alzheimer's disease blood test. Press release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.